Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million ...

Graves disease (GD)-associated hyperthyroidism is an autoimmune disorder characterized by the presence of autoantibodies that stimulate the thyroid-stimulating hormone receptor (TSHR), leading to ...

An estimated 25% to 50% of patients with autoimmune hyperthyroidism develop thyroid eye disease. In a case-control study, the prevalence of low-risk HPV was higher in patients with autoimmune ...

Viridian Therapeutics Inc. company and executive profile by Barron's. View the latest VRDN company infomation and executive ...

Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company’s lead candidate, YB-101, is a humanized ...